227 related articles for article (PubMed ID: 11933191)
1. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
[TBL] [Abstract][Full Text] [Related]
3. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
4. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.
Chou LS; Lyon E; Wittwer CT
Am J Clin Pathol; 2005 Sep; 124(3):330-8. PubMed ID: 16191501
[TBL] [Abstract][Full Text] [Related]
5. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the CFTR gene in Slovak cystic fibrosis patients by DHPLC and subsequent sequencing: identification of four novel mutations.
Kolesár P; Minárik G; Baldovic M; Ficek A; Kovács L; Kádasi L
Gen Physiol Biophys; 2008 Dec; 27(4):299-305. PubMed ID: 19202204
[TBL] [Abstract][Full Text] [Related]
7. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
9. Development of a denaturing high-performance liquid chromatography screening method for SMAD4 in juvenile polyposis syndrome.
Hatch SL; Trewick AL; Payne SJ
Ann Clin Biochem; 2007 Mar; 44(Pt 2):159-63. PubMed ID: 17362581
[TBL] [Abstract][Full Text] [Related]
10. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations.
Costes B; Fanen P; Goossens M; Ghanem N
Hum Mutat; 1993; 2(3):185-91. PubMed ID: 7689902
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency.
Ezzeldin H; Okamoto Y; Johnson MR; Diasio RB
Anal Biochem; 2002 Jul; 306(1):63-73. PubMed ID: 12069415
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC.
Su YN; Lee CN; Hung CC; Chen CA; Cheng WF; Tsao PN; Yu CL; Hsieh FJ
Hum Mutat; 2003 Oct; 22(4):326-36. PubMed ID: 12955718
[TBL] [Abstract][Full Text] [Related]
13. Identification of the commonest cystic fibrosis transmembrane regulator gene DeltaF508 mutation: evaluation of PCR--single-strand conformational polymorphism and polyacrylamide gel electrophoresis.
Kakavas KV; Noulas AV; Kanakis I; Bonanou S; Karamanos NK
Biomed Chromatogr; 2006 Oct; 20(10):1120-5. PubMed ID: 16708396
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations of dystrophin gene in DMD patients detected by rapid scanning in biplex exons DHPLC analysis.
Muscarella LA; Piemontese MR; Barbano R; Fazio A; Guarnieri V; Quattrone A; Zelante L
Biomol Eng; 2007 Jun; 24(2):231-6. PubMed ID: 17145200
[TBL] [Abstract][Full Text] [Related]
15. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
Shabbeer J; Robinson M; Desnick RJ
Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
[TBL] [Abstract][Full Text] [Related]
16. Analysis of genomic CFTR DNA.
Férec C; Le Maréchal C; Audrézet MP; Farinha CM; Amaral MD; Gallati S; Sanz J; Steiner B; Mouchel N; Harris A; Schwarz MJ
J Cyst Fibros; 2004 Aug; 3 Suppl 2():7-10. PubMed ID: 15463917
[TBL] [Abstract][Full Text] [Related]
17. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
[TBL] [Abstract][Full Text] [Related]
19. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
Greiner TC
Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort.
Bunn CF; Lintott CJ; Scott RS; George PM
Hum Mutat; 2002 Mar; 19(3):311. PubMed ID: 11857755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
